Biotech company Leap Therapeutics (NASDAQ: LPTX) today announced that it has completed a previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to launch a digital asset finance strategy.
Winklevoss Capital will provide funding and strategic support to help Leap structure and execute its digital asset financial strategy. Under the Lead Investor Agreement, the Leap Board of Directors will increase to 12 members, and Winklevoss Capital will have the right to nominate two individuals to the Leap Board, one of whom will also serve as Chairperson of the Board. Morgan, Lewis & Bockius LLP will serve as legal counsel to Leap, and Cooley LLP will serve as legal counsel to Winklevoss Capital.
Leap Therapeutics completes $58.88 million private placement to launch digital asset finance strategy
2025-10-09 11:14:32
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
Leap Therapeutics完成5888万美元私募以启动数字资产财务战略Next article：
上市公司 DevvStream购入首批22.22枚比特币
